Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/49959Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | Hendrix, Jelle | - |
| dc.contributor.advisor | Dewachter, Ilse | - |
| dc.contributor.author | SILVA, Pedro | - |
| dc.date.accessioned | 2026-09-01T10:16:39Z | - |
| dc.date.available | 2026-09-01T10:16:39Z | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-09-01T09:23:05Z | - |
| dc.identifier.uri | http://hdl.handle.net/1942/49959 | - |
| dc.description.abstract | Dementias represent the most prevalent class of diseases worldwide, marked by debilitating symptoms such as motor impairment and cognitive decline, ultimately leading to death. Despite extensive research, the mechanisms underlying disease onset remain incompletely understood. A hallmark of many dementias is the accumulation of aggregated proteins, which are now recognized to be predominantly intrinsically disordered in their monomeric form, lacking a defined tertiary structure. The microtubule-associated protein Tau is one of these intrinsically disordered proteins and has been reported to predominantly adopt a compact “paperclip-like” conformation. Importantly, Tau is implicated in several dementias, including Alzheimer’s disease, Pick’s disease, frontotemporal dementia, and corticobasal degeneration, where it aggregates into neurofibrillary tangles. Within these fibrils, individual Tau molecules exhibit a rigid core formed by the microtubule-binding region, which adopts characteristic C-shaped architectures. These observations lead us to hypothesize that aggregation is driven by conformational transitions within the monomeric protein. One suggested pathway towards aggregation is liquid-liquid phase separation, a process by which proteins partition in a dilute and a dense phase. Physiologically this process allows for higher localized protein concentration, as well as response to cellular stress. In disease, it might provide an environment which promotes conformational transitions towards disease associated structures. In this work, we aimed at studying the effect of the Tau protein integration in a crowded environment in its conformation. We applied single-molecule Förster Resonance Energy Transfer (smFRET) to investigate the structure and dynamics of the microtubule-binding region (MTBR) of Tau. In its monomeric state, the MTBR predominantly samples a compact conformation, however, it remains intrinsically disordered and transitions between extended and compact states on the microsecond timescale. The terminal domains occupy larger distances relative to the MTBR and exhibit faster conformational exchange. We also sought to characterize the physical properties of biocondensates and the conformational behavior of proteins within them. Due to their high density, biocondensates sediment to the bottom of the imaging chamber, making diffusion-based confocal methods difficult to implement. To probe the internal microenvironment, we employed raster imaging correlation spectroscopy (RICS), which quantifies molecular diffusion from confocal images. Molecules within droplets experienced markedly higher viscosity, with diffusion coefficients approximately ten-fold lower than in the dilute phase. Because smFRET inside droplets is technically challenging and time-consuming, we turned to fluorescence lifetime imaging microscopy (FLIM) to assess ensemble conformations. FLIM revealed that the MTBR adopts more compact conformations within dense phases compared to the dilute phase, consistent with structural features reported for fibril cores. To overcome sedimentation, we developed a microfluidic strategy enabling biocondensates to flow through a stationary confocal detection volume one at a time. Flow characteristics of the microfluidic chip were validated using fluorescence correlation spectroscopy, showing close agreement with simulated velocity profiles, including accelerated flow at the channel center. Droplet flow produced distinct intensity spikes corresponding to individual condensates, allowing us to determine their size distribution. Importantly, flow speed could be tuned to extend observation times, offering a promising avenue for future single-molecule studies of intradroplet conformational dynamics. | - |
| dc.description.sponsorship | Scholarship from Hasselt University (BOF20OWB16) | - |
| dc.language.iso | en | - |
| dc.publisher | Universiteit Hasselt | - |
| dc.title | Time-resolved fluorescence characterization of phase-separating proteins involved in neurodegeneration | - |
| dc.type | Theses and Dissertations | - |
| local.format.pages | 208 | - |
| local.bibliographicCitation.jcat | T1 | - |
| local.publisher.place | Hasselt | - |
| dc.relation.references | 1. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022 Feb 1;7(2):e105–25. 2. Australia D, Baker S, Banerjee S. Alzheimer’s disease international world Alzheimer report 2019: Attitudes to dementia. Alzheimer’s Disease International: London, UK [Internet]. 2019; Available from: https://scholar.google.com/citations?user=URtlq40AAAAJ&hl=en&oi=sra 3. Alzheimer’s Disease International, Guerchet M, Prince M, Prina M. Numbers of people with dementia worldwide [Internet]. 2020 [cited 2026 Mar 14]. Available from: https://www.alzint.org/resource/numbers-of-people-with-dementia-worldwide/ 4. Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023 Feb 16;186(4):693–714. 5. Gendron TF, Petrucelli L. The role of tau in neurodegeneration. Mol Neurodegener. 2009 Mar 11;4:13. 6. Goedert M, Crowther RA, Scheres SHW, Spillantini MG. Tau and neurodegeneration. Cytoskeleton (Hoboken). 2024 Jan;81(1):95–102. 7. Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016 Jan;17(1):5–21. 8. Kendrew JC, Bodo G, Dintzis HM, Parrish RG, Wyckoff H, Phillips DC. A three-dimensional model of the myoglobin molecule obtained by x-ray analysis. Nature. 1958 Mar 8;181(4610):662–6. 9. Wheeler KE, Nocek JM, Cull DA, Yatsunyk LA, Rosenzweig AC, Hoffman BM. Dynamic docking of cytochrome b5 with myoglobin and alpha-hemoglobin: heme-neutralization “squares” and the binding of electron-transfer-reactive configurations. J Am Chem Soc. 2007 Apr 4;129(13):3906–17. 10. Wright PE, Dyson HJ. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol. 1999 Oct 22;293(2):321–31. 11. Ulmer TS, Bax A, Cole NB, Nussbaum RL. Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem. 2005 Mar 11;280(10):9595–603. 12. Forman-Kay JD, Mittag T. From sequence and forces to structure, function, and evolution of intrinsically disordered proteins. Structure. 2013 Sept 3;21(9):1492–9. 13. Mittag T, Pappu RV. A conceptual framework for understanding phase separation and addressing open questions and challenges. Mol Cell. 2022 June 16;82(12):2201–14. 14. Wang B, Zhang L, Dai T, Qin Z, Lu H, Zhang L, et al. Liquid-liquid phase separation in human health and diseases. Signal Transduct Target Ther. 2021 Aug 2;6(1):290. 15. Guo T, Noble W, Hanger DP. Roles of tau protein in health and disease. Acta Neuropathol. 2017 May 6;133(5):665–704. 16. Dehmelt L, Halpain S. The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 2005;6(1):204. 17. Alquezar C, Arya S, Kao AW. Tau post-translational modifications: Dynamic transformers of tau function, degradation, and aggregation. Front Neurol. 2020;11:595532. 18. Wegmann S, Biernat J, Mandelkow E. A current view on Tau protein phosphorylation in Alzheimer’s disease. Curr Opin Neurobiol. 2021 Aug 1;69:131–8. 19. Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease. Cell. 2020 Dec 10;183(6):1699-1713.e13. 20. Xia Y, Prokop S, Giasson BI. “Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies. Mol Neurodegener. 2021 June 5;16(1):37. 21. Malia TJ, Teplyakov A, Ernst R, Wu S-J, Lacy ER, Liu X, et al. Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8: Epitope Mapping and Structure of AT8. Proteins. 2016 Apr 5;84(4):427–34. 22. Ksiezak-Reding H, He D, Gordon-Krajcer W, Kress Y, Lee S, Dickson DW. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes. Cell Motil Cytoskeleton. 2000 Nov 1;47(3):236–52. 23. El Hajjar L, Boll E, Cantrelle F-X, Bridot C, Landrieu I, Smet-Nocca C. Effect of PHF-1 hyperphosphorylation on the seeding activity of C-terminal Tau fragments. Sci Rep. 2025 Mar 22;15(1):9975. 24. Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron. 2010 Sept 23;67(6):953–66. 25. Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM, et al. Acetylated tau, a novel pathological signature in Alzheimer’s disease and other tauopathies. Brain : a journal of neurology. 2012 Mar 24;135(Pt 3):807–18. 26. Cohen TJ, Guo JL, Hurtado DE, Kwong LK, Mills IP, Trojanowski JQ, et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nature communications. 2011;2:252. 27. Harris LD, Jasem S, Licchesi JDF. The ubiquitin system in Alzheimer’s disease. Adv Exp Med Biol. 2020;1233:195–221. 28. Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021 Aug 15;596(7873):583–9. 29. Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022 Jan 7;50(D1):D439–44. 30. Varadi M, Bertoni D, Magana P, Paramval U, Pidruchna I, Radhakrishnan M, et al. AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 2024 Jan 5;52(D1):D368–75. 31. Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, Griesinger C, et al. Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol. 2009 Feb 17;7(2):e34. 32. Uversky VN, Winter S, Galzitskaya OV, Kittler L, Lober G. Hyperphosphorylation induces structural modification of tau-protein. FEBS Lett. 1998 Nov 13;439(1–2):21–5. 33. Jeganathan S, von Bergen M, Brutlach H, Steinhoff H-J, Mandelkow E. Global hairpin folding of tau in solution. Biochemistry. 2006 Feb 21;45(7):2283–93. 34. Elbaum-Garfinkle S, Rhoades E. Identification of an aggregation-prone structure of tau. J Am Chem Soc. 2012 Oct 10;134(40):16607–13. 35. Alzheimer A. Uber eigenartige Erkrankung der Hirnrinde. All Z Psychiatr [Internet]. 1907; Available from: https://cir.nii.ac.jp/crid/1571135649977545216 36. Strassnig M, Ganguli M. About a peculiar disease of the cerebral cortex: Alzheimer’s original case revisited. Psychiatry (Edgmont). 2005 Sept;2(9):30–3. 37. Brion J, Passareiro H, Nunez J, Durand J. Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d’Alzheimer. Archives de biologie. 1985;95:229–35. 38. Barghorn S, Davies P, Mandelkow E. Tau paired helical filaments from Alzheimer’s disease brain and assembled in vitro are based on beta-structure in the core domain. Biochemistry. 2004 Feb 17;43(6):1694–703. 39. Berriman J, Serpell LC, Oberg KA, Fink AL, Goedert M, Crowther RA. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc Natl Acad Sci U S A. 2003 July 22;100(15):9034–8. 40. Scheres SH, Zhang W, Falcon B, Goedert M. Cryo-EM structures of tau filaments. Curr Opin Struct Biol. 2020 Oct;64:17–25. 41. Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, et al. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature. 2017 July 13;547(7662):185–90. 42. Falcon B, Zivanov J, Zhang W, Murzin AG, Garringer HJ, Vidal R, et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019 Apr;568(7752):420–3. 43. Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, et al. Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature. 2018 Sept;561(7721):137–40. 44. Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020 Apr;580(7802):283–7. 45. Ambadipudi S, Biernat J, Riedel D, Mandelkow E, Zweckstetter M. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat Commun. 2017 Aug 17;8(1):275. 46. Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J [Internet]. 2018 Apr 3;37(7). Available from: http://dx.doi.org/10.15252/embj.201798049 47. Gu J, Chen F, Iqbal K, Gong C-X, Wang X, Liu F. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies. J Biol Chem. 2017 June 23;292(25):10600–12. 48. François-Moutal L, Perez-Miller S, Scott DD, Miranda VG, Mollasalehi N, Khanna M. Structural insights into TDP-43 and effects of post-translational modifications. Front Mol Neurosci. 2019 Dec 17;12:301. 49. Jablonski A. Efficiency of anti-stokes fluorescence in dyes. Nature. 1933 June;131(3319):839–40. 50. Lira RB, Dillingh LS, Schuringa J-J, Yahioglu G, Suhling K, Roos WH. Fluorescence lifetime imaging microscopy of flexible and rigid dyes probes the biophysical properties of synthetic and biological membranes. Biophys J. 2024 June 18;123(12):1592–609. 51. Webb RH. Confocal optical microscopy. Rep Prog Phys. 1996 Mar 1;59(3):427–71. 52. Cole RW, Jinadasa T, Brown CM. Measuring and interpreting point spread functions to determine confocal microscope resolution and ensure quality control. Nat Protoc. 2011 Nov 10;6(12):1929–41. 53. Becker W, Bergmann A, Hink MA, König K, Benndorf K, Biskup C. Fluorescence lifetime imaging by time-correlated single-photon counting: Fluorescence Lifetime Imaging by TCPSC. Microsc Res Tech. 2004 Jan 1;63(1):58–66. 54. Digman MA, Caiolfa VR, Zamai M, Gratton E. The phasor approach to fluorescence lifetime imaging analysis. Biophys J. 2008 Jan 15;94(2):L14-6. 55. Scipioni L, Rossetta A, Tedeschi G, Gratton E. Phasor S-FLIM: a new paradigm for fast and robust spectral fluorescence lifetime imaging. Nat Methods. 2021 May 15;18(5):542–50. 56. Coucke Q, Parveen N, Fernández GS, Qian C, Hofkens J, Debyser Z, et al. Particle-based phasor-FLIM-FRET resolves protein-protein interactions inside single viral particles. Biophysical reports. 2023 Sept 13;3(3):100122. 57. Vallmitjana A, Torrado B, Durkin AF, Dvornikov A, Rajil N, Ranjit S, et al. GSLab: open-source platform for advanced phasor analysis in fluorescence microscopy. Bioinformatics. 2025 Mar 29;41(4):btaf162. 58. Magde D, Elson EL, Webb WW. Fluorescence correlation spectroscopy. II. An experimental realization. Biopolymers. 1974 Jan 1;13(1):29–61. 59. Yu L, Lei Y, Ma Y, Liu M, Zheng J, Dan D, et al. A comprehensive review of fluorescence correlation spectroscopy. Front Phys. 2021 Apr 12;9:644450. 60. Digman MA, Brown CM, Sengupta P, Wiseman PW, Horwitz AR, Gratton E. Measuring fast dynamics in solutions and cells with a laser scanning microscope. Biophys J. 2005 Aug 1;89(2):1317–27. 61. Digman MA, Wiseman PW, Horwitz AR, Gratton E. Detecting protein complexes in living cells from laser scanning confocal image sequences by the cross correlation raster image spectroscopy method. Biophys J. 2009 Jan 1;96(2):707–16. 62. Ren J, Wang N, Guo P, Fan Y, Lin F, Wu J. Recent advances in microfluidics-based cell migration research. Lab Chip. 2022 Sept 13;22(18):3361–76. 63. Gural N, Irimia D. Microfluidic devices for precise measurements of cell directionality reveal a role for glutamine during cell migration. Sci Rep. 2023 Dec 27;13(1):23032. 64. Rifes P, Isaksson M, Rathore GS, Aldrin-Kirk P, Møller OK, Barzaghi G, et al. Modeling neural tube development by differentiation of human embryonic stem cells in a microfluidic WNT gradient. Nat Biotechnol. 2020 Nov 25;38(11):1265–73. 65. Duncombe TA, Tentori AM, Herr AE. Microfluidics: reframing biological enquiry. Nat Rev Mol Cell Biol. 2015 Sept;16(9):554–67. 66. Erkamp NA, Qi R, Welsh TJ, Knowles TPJ. Microfluidics for multiscale studies of biomolecular condensates. Lab Chip. 2022 Dec 20;23(1):9–24. 67. Förster T. Zwischenmolekulare energiewanderung und fluoreszenz. Ann Phys. 1948 Jan 1;437(1–2):55–75. 68. Kalinin S, Valeri A, Antonik M, Felekyan S, Seidel CAM. Detection of structural dynamics by FRET: a photon distribution and fluorescence lifetime analysis of systems with multiple states. J Phys Chem B. 2010 June 17;114(23):7983–95. 69. Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C, et al. Role of tau as a microtubule-associated protein: Structural and functional aspects. Frontiers in Aging Neuroscience [Internet]. 2019 [cited 2025 Jan 10];10(JUL). Available from: https://www.mendeley.com/catalogue/42df7fb9-8cac-3e4e-85f3-4a6666278a31/?ref=raven&dgcid=raven_md_suggest_email&dgcid=raven_md_suggest_mie_email 70. Gallo D, Ruiz A, Sánchez-Juan P. Genetic architecture of primary Tauopathies. Neuroscience. 2023 May 10;518:27–37. 71. Olfati N, Shoeibi A, Litvan I. Clinical spectrum of tauopathies. Front Neurol. 2022 July 14;13:944806. 72. Despres C, Byrne C, Qi H, Cantrelle F-X, Huvent I, Chambraud B, et al. Identification of the Tau phosphorylation pattern that drives its aggregation. Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):9080–5. 73. Flory PJ. Thermodynamics of high polymer solutions. J Chem Phys. 1942 Jan 1;10(1):51–61. 74. Huggins ML. Some properties of solutions of long-chain compounds. J Phys Chem. 1942 Jan;46(1):151–8. 75. Hochmair J, Exner C, Franck M, Dominguez-Baquero A, Diez L, Brognaro H, et al. Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of Tau condensates. EMBO J. 2022 June 1;41(11):e108882. 76. Kanaan NM, Hamel C, Grabinski T, Combs B. Liquid-liquid phase separation induces pathogenic tau conformations in vitro. Nat Commun. 2020 June 4;11(1):2809. 77. Shiramasa Y, Yamamoto R, Kashiwagi N, Sasaki F, Imai S, Ike M, et al. An aberrant fused in sarcoma liquid droplet of amyotrophic lateral sclerosis pathological variant, R495X, accelerates liquid-solid phase transition. Sci Rep. 2024 Apr 17;14(1):8914. 78. Rummens J, Khalil B, Yıldırım G, Silva P, Zorzini V, Peredo N, et al. TDP-43 seeding induces cytoplasmic aggregation heterogeneity and nuclear loss of function of TDP-43. Neuron [Internet]. 2025 Mar 28 [cited 2025 Mar 31]; Available from: http://dx.doi.org/10.1016/j.neuron.2025.03.004 79. Meneses A, Koga S, O’Leary J, Dickson DW, Bu G, Zhao N. TDP-43 pathology in Alzheimer’s disease. Mol Neurodegener. 2021 Dec 20;16(1):84. 80. Boeynaems S, Bogaert E, Kovacs D, Konijnenberg A, Timmerman E, Volkov A, et al. Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol Cell. 2017 Mar 16;65(6):1044-1055.e5. 81. Hou K, Liu T, Li J, Xian M, Sun L, Wei J. Liquid-liquid phase separation regulates alpha-synuclein aggregate and mitophagy in Parkinson’s disease. Front Neurosci. 2023 Sept 14;17:1250532. 82. Fyfe I. Tau folds differently between diseases. Nat Rev Neurol. 2018 Nov;14(11):633. 83. Lövestam S, Li D, Wagstaff JL, Kotecha A, Kimanius D, McLaughlin SH, et al. Disease-specific tau filaments assemble via polymorphic intermediates. Nature. 2024 Jan;625(7993):119–25. 84. Lerner E, Barth A, Hendrix J, Ambrose B, Birkedal V, Blanchard SC, et al. FRET-based dynamic structural biology: Challenges, perspectives and an appeal for open-science practices. Elife [Internet]. 2021 Mar 29 [cited 2025 July 18];10. Available from: http://dx.doi.org/10.7554/eLife.60416 85. Brucale M, Schuler B, Samorì B. Single-molecule studies of intrinsically disordered proteins. Chem Rev. 2014 Mar 26;114(6):3281–317. 86. Schuler B, Soranno A, Hofmann H, Nettels D. Single-Molecule FRET Spectroscopy and the Polymer Physics of Unfolded and Intrinsically Disordered Proteins. Annu Rev Biophys. 2016 July 5;45:207–31. 87. Wen J, Hong L, Krainer G, Yao Q-Q, Knowles TPJ, Wu S, et al. Conformational expansion of Tau in condensates promotes irreversible aggregation. J Am Chem Soc. 2021 Aug 25;143(33):13056–64. 88. Wen J, Tang Y, Sneideris T, Ausserwöger H, Hong L, Knowles TPJ, et al. Direct observation of the conformational transitions in Tau and their correlation with phase behavior. JACS Au. 2025 Sept 22;5(9):4268–80. 89. Kudryavtsev V, Sikor M, Kalinin S, Mokranjac D, Seidel CAM, Lamb DC. Combining MFD and PIE for accurate single‐pair Förster resonance energy transfer measurements. Chemphyschem. 2012 Mar;13(4):1060–78. 90. Deniz AA, Laurence TA, Beligere GS, Dahan M, Martin AB, Chemla DS, et al. Single-molecule protein folding: diffusion fluorescence resonance energy transfer studies of the denaturation of chymotrypsin inhibitor 2. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5179–84. 91. Maus M, Cotlet M, Hofkens J, Gensch T, De Schryver FC, Schaffer J, et al. An experimental comparison of the maximum likelihood estimation and nonlinear least-squares fluorescence lifetime analysis of single molecules. Anal Chem. 2001 May 1;73(9):2078–86. 92. Felekyan S, Kalinin S, Sanabria H, Valeri A, Seidel CAM. Filtered FCS: species auto- and cross-correlation functions highlight binding and dynamics in biomolecules. Chemphyschem. 2012 Mar;13(4):1036–53. 93. Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow E-M, Mandelkow E. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J Biol Chem. 2008 Nov 14;283(46):32066–76. 94. Wegmann S. Liquid-liquid phase separation of tau protein in neurobiology and pathology. Adv Exp Med Biol. 2019;1184:341–57. 95. Torrado B, Pannunzio B, Malacrida L, Digman MA. Fluorescence lifetime imaging microscopy. Nat Rev Methods Primers. 2024 Nov 7;4(1):1–23. 96. Coucke Q, Vorsselmans S, Aytekin S, Huysecom S, Hofkens J, Hendrix J, et al. Navigating FRET Imaging Techniques for Biosensor Applications [Internet]. 2024 [cited 2026 Jan 23]. Available from: https://osf.io/preprints/osf/ye4dm_v1 97. Mylonas E, Hascher A, Bernadó P, Blackledge M, Mandelkow E, Svergun DI. Domain conformation of tau protein studied by solution small-angle X-ray scattering. Biochemistry. 2008 Sept 30;47(39):10345–53. 98. Schuler B. Perspective: Chain dynamics of unfolded and intrinsically disordered proteins from nanosecond fluorescence correlation spectroscopy combined with single-molecule FRET. J Chem Phys. 2018 July 7;149(1):010901. 99. Huang RY-C, Iacob RE, Sankaranarayanan S, Yang L, Ahlijanian M, Tao L, et al. Probing conformational dynamics of tau protein by hydrogen/deuterium exchange mass spectrometry. J Am Soc Mass Spectrom. 2018 Jan;29(1):174–82. 100. Zhu S, Shala A, Bezginov A, Sljoka A, Audette G, Wilson DJ. Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble. PLoS One. 2015 Mar 13;10(3):e0120416. 101. Gandhi NS, Landrieu I, Byrne C, Kukic P, Amniai L, Cantrelle F-X, et al. A phosphorylation-induced turn defines the Alzheimer’s disease AT8 antibody Epitope on the tau protein. Angew Chem Int Ed Engl. 2015 June 1;54(23):6819–23. 102. Najafi S, Lin Y, Longhini AP, Zhang X, Delaney KT, Kosik KS, et al. Liquid-liquid phase separation of Tau by self and complex coacervation. Protein Sci. 2021 July 19;30(7):1393–407. 103. Gilbert MAG, Fatima N, Jenkins J, O’Sullivan TJ, Schertel A, Halfon Y, et al. CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain. Nature. 2024 July 10;631(8022):913–9. 104. Zhang W, Falcon B, Murzin AG, Fan J, Crowther RA, Goedert M, et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases. Elife. 2019 Feb 5;8:e43584. 105. Rodríguez LC, Foressi NN, Celej MS. Liquid-liquid phase separation of tau and α-synuclein: A new pathway of overlapping neuropathologies. Biochem Biophys Res Commun. 2024 Dec 31;741(151053):151053. 106. Dilissen S, Silva PL, Smolentseva A, Kache T, Thoelen R, Hendrix J. Characterisation of biocondensate microfluidic flow using array-detector FCS. Biochimica et Biophysica Acta (BBA) - General Subjects. 2024 Sept 1;1868(9):130673. 107. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol. 1997 May 1;185(1):82–91. 108. Schrimpf W, Barth A, Hendrix J, Lamb DC. PAM: A Framework for Integrated Analysis of Imaging, Single-Molecule, and Ensemble Fluorescence Data. Biophys J. 2018 Apr 10;114(7):1518–28. 109. Tomov TE, Tsukanov R, Masoud R, Liber M, Plavner N, Nir E. Disentangling subpopulations in single-molecule FRET and ALEX experiments with photon distribution analysis. Biophys J. 2012 Mar 7;102(5):1163–73. 110. Torella JP, Holden SJ, Santoso Y, Hohlbein J, Kapanidis AN. Identifying molecular dynamics in single-molecule FRET experiments with burst variance analysis. Biophys J. 2011 Mar 16;100(6):1568–77. 111. Maslov I, Volkov O, Khorn P, Orekhov P, Gusach A, Kuzmichev P, et al. Sub-millisecond conformational dynamics of the A2A adenosine receptor revealed by single-molecule FRET. Commun Biol. 2023 Apr 3;6(1):362. 112. Salehirozveh M, Kure Larsen A-K, Stojmenovic M, Thei F, Dong M. In-situ PLL-g-PEG functionalized nanopore for enhancing protein characterization. Chem Asian J. 2023 Sept 1;18(17):e202300515. 113. Gialdini I, Hendrix J, Lamb DC. There is more to scanning than meets the eye: Raster Image Correlation Spectroscopy. Biochim Biophys Acta Gen Subj. 2025 July 1;1869(8):130818. 114. Longfils M, Smisdom N, Ameloot M, Rudemo M, Lemmens V, Fernández GS, et al. Raster image correlation spectroscopy performance evaluation. Biophys J. 2019 Nov 19;117(10):1900–14. 115. Schrimpf W, Lemmens V, Smisdom N, Ameloot M, Lamb DC, Hendrix J. Crosstalk-free multicolor RICS using spectral weighting. Methods. 2018 May 1;140–141:97–111. 116. Chebaro Y, Ballard AJ, Chakraborty D, Wales DJ. Intrinsically disordered energy landscapes. Sci Rep. 2015 May 22;5(1):10386. 117. Hyman AA, Weber CA, Jülicher F. Liquid-liquid phase separation in biology. Annu Rev Cell Dev Biol. 2014;30:39–58. 118. Alberti S, Dormann D. Liquid-Liquid Phase Separation in Disease. Annu Rev Genet. 2019 Dec 3;53:171–94. 119. Hervy J, Bicout DJ. Dynamical decoration of stabilized-microtubules by Tau-proteins. Sci Rep. 2019 Aug 28;9(1):12473. 120. Li X-H, Culver JA, Rhoades E. Tau Binds to Multiple Tubulin Dimers with Helical Structure. J Am Chem Soc. 2015 July 29;137(29):9218–21. 121. Scheres SHW, Ryskeldi-Falcon B, Goedert M. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids. Nature. 2023 Sept;621(7980):701–10. 122. Agam G, Gebhardt C, Popara M, Mächtel R, Folz J, Ambrose B, et al. Reliability and accuracy of single-molecule FRET studies for characterization of structural dynamics and distances in proteins. Nat Methods. 2023 Apr;20(4):523–35. 123. Zheng W, Dignon GL, Jovic N, Xu X, Regy RM, Fawzi NL, et al. Molecular Details of Protein Condensates Probed by Microsecond Long Atomistic Simulations. J Phys Chem B. 2020 Dec 24;124(51):11671–9. 124. Galvanetto N, Ivanović MT, Chowdhury A, Sottini A, Nüesch MF, Nettels D, et al. Extreme dynamics in a biomolecular condensate. Nature. 2023 July;619(7971):876–83. 125. Gharib G, Bütün İ, Muganlı Z, Kozalak G, Namlı İ, Sarraf SS, et al. Biomedical Applications of Microfluidic Devices: A Review. Biosensors [Internet]. 2022 Nov 16;12(11). Available from: http://dx.doi.org/10.3390/bios12111023 126. Linsenmeier M, Kopp MRG, Stavrakis S, de Mello A, Arosio P. Analysis of biomolecular condensates and protein phase separation with microfluidic technology. Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118823. 127. Niculescu A-G, Chircov C, Bîrcă AC, Grumezescu AM. Fabrication and Applications of Microfluidic Devices: A Review. Int J Mol Sci [Internet]. 2021 Feb 18;22(4). Available from: http://dx.doi.org/10.3390/ijms22042011 128. Rhine K, Skanchy S, Myong S. Single-molecule and ensemble methods to probe RNP nucleation and condensate properties. Methods. 2022 Jan;197:74–81. 129. Pokhrel P, Jonchhe S, Pan W, Mao H. Single-Molecular Dissection of Liquid-Liquid Phase Transitions. J Am Chem Soc. 2023 Aug 9;145(31):17143–50. 130. Magde D, Webb WW, Elson EL. Fluorescence correlation spectroscopy. III. Uniform translation and laminar flow. Biopolymers. 1978 Feb;17(2):361–76. 131. Digman MA, Gratton E. Imaging barriers to diffusion by pair correlation functions. Biophys J. 2009 July 22;97(2):665–73. 132. Brinkmeier M, Dörre K, Stephan J, Eigen M. Two-beam cross-correlation: a method to characterize transport phenomena in micrometer-sized structures. Anal Chem. 1999 Feb 1;71(3):609–16. 133. Arbour TJ, Enderlein J. Application of dual-focus fluorescence correlation spectroscopy to microfluidic flow-velocity measurement. Lab Chip. 2010 May 21;10(10):1286–92. 134. Scipioni L, Lanzanó L, Diaspro A, Gratton E. Comprehensive correlation analysis for super-resolution dynamic fingerprinting of cellular compartments using the Zeiss Airyscan detector. Nat Commun. 2018 Nov 30;9(1):5120. 135. Slenders E, Castello M, Buttafava M, Villa F, Tosi A, Lanzanò L, et al. Confocal-based fluorescence fluctuation spectroscopy with a SPAD array detector. Light Sci Appl. 2021 Feb 5;10(1):31. 136. Annette Bergter, Hanna Reuter, Georg Wieser, Stanislav Kalinin, Volodymyr Kudryavtsev, Dieter Huhse. Follow dynamic biological processes and reveal spatial molecular characteristics - ZEISS Dynamics Profiler. Carl Zeiss Microscopy GmbH; 2023 June. 137. Stone HA. Introduction to Fluid Dynamics for Microfluidic Flows. In: Lee H, Westervelt RM, Ham D, editors. CMOS Biotechnology. Boston, MA: Springer US; 2007. p. 5–30. 138. Bruus H. Governing Equations in Microfluidics. In 2014. 139. Huber D, Oskooei A, Casadevall I Solvas X, Andrew deMello, Kaigala GV. Hydrodynamics in Cell Studies. Chem Rev. 2018 Feb 28;118(4):2042–79. 140. Peter Kapusta, PicoQuant GmbH. Absolute Diffusion Coefficients: Compilation of Reference Data for FCS Calibration. 2010 July. 141. Pisapia F, Balachandran W, Rasekh M. Organ-on-a-Chip: Design and Simulation of Various Microfluidic Channel Geometries for the Influence of Fluid Dynamic Parameters. NATO Adv Sci Inst Ser E Appl Sci. 2022 Apr 11;12(8):3829. 142. Nicovich PR, Dickson RM. Three-dimensional Flow Mapping in Microfluidic Channels with Widefield Cross-correlation Microscopy. Isr J Chem. 2010 Apr 1;49(3–4):293–301. 143. Kuricheti KK, Buschmann V, Weston KD. Application of fluorescence correlation spectroscopy for velocity imaging in microfluidic devices. Appl Spectrosc. 2004 Oct;58(10):1180–6. 144. Gosch M, Blom H, Holm J, Heino T, Rigler R. Hydrodynamic flow profiling in microchannel structures by single molecule fluorescence correlation spectroscopy. Anal Chem. 2000 July 15;72(14):3260–5. 145. Kitahara R, Yamazaki R, Ide F, Li S, Shiramasa Y, Sasahara N, et al. Pressure-Jump Kinetics of Liquid-Liquid Phase Separation: Comparison of Two Different Condensed Phases of the RNA-Binding Protein, Fused in Sarcoma. J Am Chem Soc. 2021 Dec 1;143(47):19697–702. 146. Li S, Yoshizawa T, Yamazaki R, Fujiwara A, Kameda T, Kitahara R. Pressure and Temperature Phase Diagram for Liquid-Liquid Phase Separation of the RNA-Binding Protein Fused in Sarcoma. J Phys Chem B. 2021 July 1;125(25):6821–9. 147. Carlo DD, Irimia D, Tompkins RG, Toner M. Continuous inertial focusing, ordering, and separation of particles in microchannels. Proceedings of the National Academy of Sciences. 2007;104(48):18892–7. 148. Sohrabi Kashani A, Packirisamy M. Efficient Low Shear Flow-based Trapping of Biological Entities. Sci Rep. 2019 Apr 2;9(1):5511. 149. Tabeling P. Introduction to Microfluidics. Oxford University Press; 2023. 150. Huber ML, Perkins RA, Laesecke A, Friend DG, Sengers JV, Assael MJ, et al. New International Formulation for the Viscosity of H2O. J Phys Chem Ref Data. 2009 June 1;38(2):101–25. 151. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, NY). 2006 Oct 6;314(5796):130–3. 152. Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016 Nov 10;539(7628):197–206. 153. Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013 Aug 7;79(3):416–38. 154. Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain : a journal of neurology. 2019 June 1;142(6):1503–27. 155. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (New York, NY). 2008 Mar 21;319(5870):1668–72. 156. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nature genetics. 2008 May 30;40(5):572–4. 157. Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Human Genetics. 2017;136(9):1193–214. 158. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neuroscience. 2011 Apr 27;14(4):459–68. 159. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nature Neuroscience. 2011 Apr 27;14(4):452–8. 160. Butti Z, Patten SA. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Frontiers in genetics. 2018 Jan 22;9(JAN):712. 161. Piol D, Robberechts T, Da Cruz S. Lost in local translation: TDP-43 and FUS in axonal/neuromuscular junction maintenance and dysregulation in amyotrophic lateral sclerosis. Neuron. 2023;111(9):1355–80. 162. Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Human molecular genetics. 2010 Apr 15;19(R1):R46-64. 163. Boeynaems S, Alberti S, Fawzi NL, Mittag T, Polymenidou M, Rousseau F, et al. Protein Phase Separation: A New Phase in Cell Biology. Trends in Cell Biology. 2018;28(6):420–35. 164. Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, et al. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron. 2019 Apr 17;102(2):339-357.e7. 165. Gopal PP, Nirschl JJ, Klinman E, Holzbaur ELF. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proceedings of the National Academy of Sciences of the United States of America. 2017 Mar 21;114(12):E2466–75. 166. Hallegger M, Chakrabarti AM, Lee FCY, Lee BL, Amalietti AG, Odeh HM, et al. TDP-43 condensation properties specify its RNA-binding and regulatory repertoire. Cell. 2021 Sept 2;184(18):4680-4696.e22. 167. Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science (New York, NY). 2018 May 25;360(6391):918–21. 168. Conicella AE, Zerze GH, Mittal J, Fawzi NL. ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure. 2016 Sept 6;24(9):1537–49. 169. McGurk L, Gomes E, Guo L, Mojsilovic-Petrovic J, Tran V, Kalb RG, et al. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Molecular Cell. 2018;71(5):703-717.e9. 170. Pakravan D, Michiels E, Bratek-Skicki A, De Decker M, Van Lindt J, Alsteens D, et al. Liquid-Liquid Phase Separation Enhances TDP-43 LCD Aggregation but Delays Seeded Aggregation. Biomolecules [Internet]. 2021 Apr 8;11(4). Available from: http://dx.doi.org/10.3390/biom11040548 171. Gruijs da Silva LA, Simonetti F, Hutten S, Riemenschneider H, Sternburg EL, Pietrek LM, et al. Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation. The EMBO journal. 2022 Apr 19;41(8):e108443. 172. Keating SS, Bademosi AT, San Gil R, Walker AK. Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43. Cellular and molecular life sciences : CMLS. 2023 Mar 17;80(4):95. 173. Koehler LC, Grese ZR, Bastos ACS, Mamede LD, Heyduk T, Ayala YM. TDP-43 Oligomerization and Phase Separation Properties Are Necessary for Autoregulation. Frontiers in Neuroscience. 2022;16(April):1–15. 174. Guenther EL, Cao Q, Trinh H, Lu J, Sawaya MR, Cascio D, et al. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nature Structural and Molecular Biology. 2018;25(6):463–71. 175. Li Q, Babinchak WM, Surewicz WK. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43. Nature Communications. 2021;12(1):1–8. 176. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. Journal of Biological Chemistry. 2009;284(30):20329–39. 177. Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019 Apr 17;102(2):321-338.e8. 178. Alberti S, Hyman AA. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nature Reviews Molecular Cell Biology. 2021 Mar 28;22(3):196–213. 179. Kawakami I, Arai T, Hasegawa M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta neuropathologica. 2019 Nov;138(5):751–70. 180. Laferrière F, Maniecka Z, Pérez-Berlanga M, Hruska-Plochan M, Gilhespy L, Hock EM, et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nature Neuroscience. 2019 Jan 1;22(1):65–77. 181. Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Annals of Neurology. 2013;74(1):20–38. 182. Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathologica. 2014;127(3):423–39. 183. Kumar ST, Nazarov S, Porta S, Maharjan N, Cendrowska U, Kabani M, et al. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nature Neuroscience. 2023;26(6):983–96. 184. Nonaka T, Hasegawa M. Prion-like properties of assembled TDP-43. Current Opinion in Neurobiology. 2020;61:23–8. 185. De Rossi P, Lewis AJ, Furrer J, De Vos L, Demeter T, Zbinden A, et al. FTLD‐TDP assemblies seed neoaggregates with subtype‐specific features via a prion‐like cascade. EMBO reports. 2021;22(12):1–20. 186. Smethurst P, Newcombe J, Troakes C, Simone R, Chen YR, Patani R, et al. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiology of Disease. 2016;96:236–47. 187. Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nature communications. 2018 Oct 11;9(1):4220. 188. Lam AJ, St-Pierre F, Gong Y, Marshall JD, Cranfill PJ, Baird MA, et al. Improving FRET dynamic range with bright green and red fluorescent proteins. Nature Methods. 2012;9(10):1005–12. 189. Joron K, Viegas JO, Haas-Neill L, Bier S, Drori P, Dvir S, et al. Fluorescent protein lifetimes report densities and phases of nuclear condensates during embryonic stem-cell differentiation. Nature communications. 2023 Aug 12;14(1):4885. 190. Quan MD, Liao SCJ, Ferreon JC, Ferreon ACM. Fluorescence Lifetime Imaging Microscopy of Biomolecular Condensates. Methods in Molecular Biology. 2023;2563:135–48. 191. Hardenberg MC, Sinnige T, Casford S, Dada ST, Poudel C, Robinson EA, et al. Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies. Journal of molecular cell biology. 2021;13(4):282–94. 192. Tittelmeier J, Druffel-Augustin S, Alik A, Melki R, Nussbaum-Krammer C. Dissecting aggregation and seeding dynamics of α-Syn polymorphs using the phasor approach to FLIM. Communications Biology. 2022;5(1):1–13. 193. Gallrein C, Iburg M, Michelberger T, Koçak A, Puchkov D, Liu F, et al. Novel amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity. Progress in Neurobiology. 2021;198:101907. 194. Galvanetto N, Ivanović MT, Chowdhury A, Sottini A, Nüesch MF, Nettels D, et al. Extreme dynamics in a biomolecular condensate. Nature. 2023 July 19;619(7971):876–83. 195. Nüesch MF, Pietrek L, Holmstrom ED, Nettels D, von Roten V, Kronenberg-Tenga R, et al. Nanosecond chain dynamics of single-stranded nucleic acids. Nat Commun. 2024 July 17;15(1):6010. 196. Melo AM, Coraor J, Alpha-Cobb G, Elbaum-Garfinkle S, Nath A, Rhoades E. A functional role for intrinsic disorder in the tau-tubulin complex. Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14336–41. 197. Li X-H, Rhoades E. Heterogeneous Tau-Tubulin Complexes Accelerate Microtubule Polymerization. Biophys J. 2017 June 20;112(12):2567–74. 198. Sano Y, Itoh Y, Kamonprasertsuk S, Suzuki L, Fukasawa A, Oikawa H, et al. Simple and efficient detection scheme of two-color fluorescence correlation spectroscopy for protein dynamics investigation from nanoseconds to milliseconds. ACS Phys Chem Au. 2024 Jan 24;4(1):85–93. 199. Mitrea DM, Mittasch M, Gomes BF, Klein IA, Murcko MA. Modulating biomolecular condensates: a novel approach to drug discovery. Nat Rev Drug Discov. 2022 Nov 16;21(11):841–62. | - |
| local.type.refereed | Non-Refereed | - |
| local.type.specified | Phd thesis | - |
| local.provider.type | - | |
| local.uhasselt.international | no | - |
| item.fulltext | With Fulltext | - |
| item.contributor | SILVA, Pedro | - |
| item.accessRights | Embargoed Access | - |
| item.embargoEndDate | 2029-09-04 | - |
| item.fullcitation | SILVA, Pedro (2026) Time-resolved fluorescence characterization of phase-separating proteins involved in neurodegeneration. | - |
| Appears in Collections: | Research publications | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Time-resolved fluorescence characterization of phase-separating proteins involved in neurodegeneration.pdf Until 2029-09-04 | Published version | 33.45 MB | Adobe PDF | View/Open Request a copy |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.